The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,370.00
Bid: 12,370.00
Ask: 12,374.00
Change: 38.00 (0.31%)
Spread: 4.00 (0.032%)
Open: 12,350.00
High: 12,432.00
Low: 12,314.00
Prev. Close: 12,332.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-FTSE 100 leaps to five-month high on vaccine optimism

Wed, 11th Nov 2020 09:31

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)

* Flutter, BAE Systems jump on raising profit forecast

* Workspace slips on first-half loss, dividend push back

* FTSE 100 up 1.4%, FTSE 250 adds 1.6%
(Updates to close)

By Devik Jain

Nov 11 (Reuters) - London stocks jumped on Wednesday,
logging nearly 8% gains this week, as optimism about an
effective COVID-19 vaccine offset concerns over surging
coronavirus cases and a deadlock in Brexit trade talks with the
European Union.

The blue-chip FTSE 100 index closed up 1.4%,
touching its highest level since June 10, with British Airways
owner IAG rising 8% after Goldman Sachs upgraded the
stock to 'buy'.

A weaker sterling also boosted dollar earners such as
AstraZeneca Plc, British American Tobacco Plc
and Unilever Plc and HSBC Holdings Plc.

The domestically focused mid-cap FTSE 250 ended 1.6%
higher, boosted by financial and real estate
stocks.

"This week's news on a vaccine, while welcome, does not
change the fact that France, Germany and the UK are still in the
middle of partial economic lockdowns," Michael Hewson, chief
market analyst at CMC Markets, wrote in a note.

"However, for now markets appear content to ignore this and
are focusing on the potential green pastures of a post-pandemic
world, with a workable vaccine."

After falling nearly 5% in October, the FTSE 100 is up more
than 14% this month, outperforming its U.S. and European peers
as a slew of stimulus measures and positive vaccine data
supported hopes of a sooner-than-expected economic recovery.

England's Deputy Chief Medical Officer Jonathan Van-Tam said
the country was ready to roll out a vaccine once regulators
approved it as safe, as it grapples with more than 61,000
COVID-related deaths, Europe's highest toll.

Brexit news also drew attention with Prime Minister Boris
Johnson saying he was hopeful a trade deal with the EU could
still be agreed, but that Brussels needed to understand
Britain's priorities.

Workspace Group slipped 2.5%, after it swung to a
first-half loss and deferred a decision on full-year dividend.

Online betting group Flutter Entertainment and
defence company BAE Systems Plc jumped 5% and 2.5%
respectively, after they raised their annual earnings forecast.
(Reporting by Devik Jain in Bengaluru; Editing by Bernard Orr,
Anil D'Silva and Mark Heinrich)

More News
1 Dec 2023 08:33

AstraZeneca discontinues two phase III evidence trials for Lokelma

(Alliance News) - AstraZeneca on Friday said it has decided to discontinue the Stabilize-CKD and Dialize-outcomes phase III trials for Lokelma, citing increased enrolment timelines.

Read more
1 Dec 2023 08:01

AstraZeneca calls off two phase III trials into hyperkalaemia treatment

(Sharecast News) - Drugmaker AstraZeneca has called off two phase III trials on its hyperkalaemia treatment after a series of logistical challenges.

Read more
1 Dec 2023 07:41

LONDON BRIEFING: Stocks called higher; UK house prices fall annually

(Alliance News) - Stocks in London are called to open higher on Friday, following data from Nationwide showing that the annual pace of UK house price decline slowed in November.

Read more
27 Nov 2023 16:12

London close: Stocks start week in subdued state

(Sharecast News) - London's financial markets saw a somewhat subdued performance on Monday, as concerns regarding the Chinese economy cast a shadow over investor sentiment.

Read more
27 Nov 2023 09:20

LONDON BROKER RATINGS: Peel, Numis up Rightmove; Goldman cuts Entain

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
23 Nov 2023 18:41

IN BRIEF: AstraZeneca Chair Demare buys shares for over GBP200,000

AstraZeneca PLC - Cambridge-based pharmaceutical company - Chair Michel Demare buys 2,000 shares in total on Wednesday and Tuesday. Buys 1,000 shares for GBP101.05 each on Tuesday and 1,000 shares for GBP101.70 each on Thursday, for a total of GBP202,752.

Read more
20 Nov 2023 10:49

AstraZeneca launches new life sciences tech innovation firm Evinova

(Alliance News) - AstraZeneca PLC on Monday launched Evinova, a new health technology business focused on accelerating innovation across the life sciences sector, delivery of clinical trials and better health outcomes.

Read more
17 Nov 2023 15:20

London close: Stocks higher despite weaker retail sales data

(Sharecast News) - London's stock markets finished in a positive state on Friday despite weaker-than-expected UK retail sales figures.

Read more
17 Nov 2023 12:00

LONDON MARKET MIDDAY: Stocks shrug off downbeat UK retail sales

(Alliance News) - Stock prices in London were up at midday on Friday, as a week of favourable data as far as inflation goes gave investors a reason to overlook disappointing UK retail sales figures.

Read more
17 Nov 2023 09:03

LONDON MARKET OPEN: Stocks up despite UK retail sales growth miss

(Alliance News) - Stock prices in London opened higher on Friday, despite weaker-than-expected October retail sales figures for the UK.

Read more
17 Nov 2023 08:31

TOP NEWS: US approves AstraZeneca's Truqap for form of breast cancer

(Alliance News) - AstraZeneca PLC on Friday said that the US Food & Drug Administration approved its drug Truqap in combination with Faslodex to treat patients with an advanced form of breast cancer.

Read more
17 Nov 2023 07:58

LONDON BRIEFING: UK retail sales fall; AstraZeneca gets US approval

(Alliance News) - Stock prices in London are still set to open higher on Friday, despite October retail sales figures for the UK disappointing shortly before the opening bell.

Read more
17 Nov 2023 07:16

AstraZeneca gets US approval for breast cancer treatment

(Sharecast News) - AstraZeneca's 'Truqap', or capivasertib, in combination with 'Faslodex', or fulvestrant, has secured approval from the US Food and Drug Administration (FDA) for specific breast cancer treatments, the company announced on Friday.

Read more
14 Nov 2023 10:51

TOP NEWS: AstraZeneca Imfinzi fails to meet endpoint in cancer trial

(Alliance News) - AstraZeneca PLC on Tuesday said the Pacific-2 phase III trial for Imfinzi as an early treatment lung cancer immunotherapy treatment administered with chemoradiotherapy, did not meet its primary endpoint.

Read more
14 Nov 2023 09:22

AstraZeneca's latest lung cancer trial fails its primary endpoint

(Sharecast News) - AstraZeneca announced on Tuesday that its 'PACIFIC-2' phase three trial for Imfinzi, or durvalumab, concurrently administered with chemoradiotherapy (CRT), did not achieve its primary endpoint of progression-free survival compared to CRT alone.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.